Abdominal symptom score test for people with cystic fibrosis
Part of Digestive system, Genetic & congenital, Hormones & metabolism, Lungs & breathing clinical trials.
This trial helps create and check a patient-friendly questionnaire that measures abdominal (belly) involvement in cystic fibrosis. It may help your care team better track symptoms over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- If you have cystic fibrosis, you must meet the study’s CF diagnosis standard (sweat test or genetic testing).
- If you do not have cystic fibrosis, you must be a similar age to the people with CF in the study.
- You (and your family, if needed) must be able to understand and cooperate with the study tasks.
- If you are a healthy control, you must not have other conditions that can cause belly symptoms (like celiac disease or inflammatory bowel disease).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well CFTR-modulator medicines are working in people with cystic fibrosis, by checking specific “biomarkers” (measurable signals) in samples. Your care team may use the results to better understand how these medicines help, especially for certain CFTR changes.
This registry study collects information and measures lung function to better understand respiratory health across people with cystic fibrosis, other lung diseases, and healthy volunteers. Your results may help researchers track lung health and improve future research and care.
This trial tests a new device that measures how your sweat glands react to a common asthma medication. It aims to better classify people with cystic fibrosis or related diseases, and also includes healthy volunteers and carriers.
This study is a registry that collects health information (and some lab samples) from Chinese children who may have cystic fibrosis (CF). It helps researchers better understand CF in children and how it is diagnosed.
This trial tests a new skin sensor that measures sweat to help diagnose cystic fibrosis. It compares results from people with CF and healthy volunteers to see if the device works accurately.
This study looks for simple signals (markers) that may show whether cystic fibrosis treatments are working. It includes people who take CF “modulator” medicines like ivacaftor, people who don’t, and people whose cystic fibrosis was ruled out after testing.
Hear when a new Cystic Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.